Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis -: A paired comparison study

被引:92
|
作者
Tanew, A
Radakovic-Fijan, S
Schemper, M
Hönigsmann, H
机构
[1] Univ Vienna, Sch Med, Dept Dermatol, Div Special & Environm Dermatol, A-1090 Vienna, Austria
[2] Univ Vienna, Sch Med, Dept Med Comp Sci, Sect Clin Biometr, A-1090 Vienna, Austria
关键词
D O I
10.1001/archderm.135.5.519
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To compare the therapeutic efficacy of narrowband (TL-01) UV-B phototherapy vs photochemotherapy (psoralen-W-A [PUVA]) in patients with chronic plaque-type psoriasis. Design: Open, nonrandomized, intraindividually controlled paired comparison study. Setting: Phototherapeutic unit in a university hospital. Patients: Twenty-five patients with chronic plaque-type psoriasis. Interventions: Paired irradiations with threshold erythemogenic doses of narrowband UV-B and PUVA were given to the patients' dorsal aspect including the arms and legs. Treatment was performed 3 times weekly until complete or almost complete clearing with one or both regimens or over a maximum period of 18 exposures. Main Outcome Measures: Assessment of the Psoriasis Area and Severity Index (PASI) in each half of the patient's dorsal aspect before and after treatment with the 2 regimens. Results: The median pretreatment PASI score of 16 (range, 6.2-23.4) was reduced by 84% to 2.5 (range, 0-12.6) by the narrowband UV-B treatment and by 89% to 1.8 (range, 0-8.2) by the PUVA treatment. Statistical analysis of these data showed a tendency for PUVA being superior to narrowband UV-B although the difference remained below the level of significance (P=.17). However, a clear effect of the pretreatment PASI score on the therapeutic outcome was found. Patients with higher baseline PASI scores responded significantly better to PUVA than to narrowband UV-B (P=.03). Conclusions: Our data demonstrate that in many patients with plaque-type psoriasis, narrowband UV-B is comparably as effective as PUVA and, given the lack of photosensitizer-related adverse reactions and the possibly lower long-term cancer risk, can be considered as first-line treatment. Treatment with PUVA, on the other hand, remains the mainstay for patients with high PASI scores who do not respond or whose psoriasis cannot be controlled adequately by narrowband UV-B.
引用
收藏
页码:519 / 524
页数:6
相关论文
共 50 条
  • [31] Narrowband UV-B phototherapy clears psoriasis through a combination of local and systemic effects
    Gibbs, NK
    ARCHIVES OF DERMATOLOGY, 2003, 139 (05) : 665 - 665
  • [32] Treatment of localized persistent plaque psoriasis with incoherent narrowband ultraviolet B phototherapy
    Toll, A
    Vélez-González, M
    Gallardo, F
    Gilaberte, M
    Pujol, RM
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2005, 16 (03) : 165 - 168
  • [33] A Randomized Comparison of Methods of Selecting Narrowband UV-B Starting Dose to Treat Chronic Psoriasis
    Dawe, Robert S.
    Cameron, Heather M.
    Yule, Susan
    Ibbotson, Sally H.
    Moseley, Harry H.
    Ferguson, James
    ARCHIVES OF DERMATOLOGY, 2011, 147 (02) : 168 - 174
  • [34] Efficacy of a far erythemogenic dose of narrow-band ultraviolet B phototherapy in chronic plaque-type psoriasis
    Akaraphanth, Rutsanee
    Kittipavara, Yotsinee
    Voravutinon, Nataya
    Wachiratarapadorn, Usa
    Gritiyarangsan, Pimonpun
    JOURNAL OF DERMATOLOGY, 2010, 37 (02): : 140 - 145
  • [35] Comparison of topical 8-methoxypsoralen and narrowband ultraviolet B with narrowband ultraviolet B alone in treatment-resistant sites in plaque-type psoriasis: a placebo-controlled study
    Ehsani, Amir-Houshang
    Ghaninejad, Haydeh
    Kiani, Amin
    Daneshpazhooh, Maryam
    Hosseini, S. Hamed
    Noormohammadpoor, Pedram
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2011, 27 (06) : 294 - 296
  • [36] Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease
    Grundmann-Kollmann, M
    Martin, H
    Ludwig, R
    Klein, S
    Boehncke, WH
    Hoelzer, D
    Kaufmann, R
    Podda, M
    TRANSPLANTATION, 2002, 74 (11) : 1631 - 1634
  • [37] Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review
    Archier, E.
    Devaux, S.
    Castela, E.
    Gallini, A.
    Aubin, F.
    Le Maitre, M.
    Aractingi, S.
    Bachelez, H.
    Cribier, B.
    Joly, P.
    Jullien, D.
    Misery, L.
    Paul, C.
    Ortonne, J-P
    Richard, M-A
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 : 22 - 31
  • [38] Narrowband UV-B Phototherapy in the Treatment of Generalized Hailey-Hailey Disease
    Abaca, M. C.
    Flores, L.
    Parra, V.
    ACTAS DERMO-SIFILIOGRAFICAS, 2018, 109 (10): : 924 - 927
  • [39] Afamelanotide and Narrowband UV-B Phototherapy for the Treatment of Vitiligo A Randomized Multicenter Trial
    Lim, Henry W.
    Grimes, Pearl E.
    Agbai, Oma
    Hamzavi, Iltefat
    Henderson, Marsha
    Haddican, Madelaine
    Linkner, Rita V.
    Lebwohl, Mark
    JAMA DERMATOLOGY, 2015, 151 (01) : 42 - 50
  • [40] Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis The LITE Randomized Clinical Trial
    Gelfand, Joel M.
    Armstrong, April W.
    Lim, Henry W.
    Feldman, Steven R.
    Johnson, Sandra M.
    Claiborne, W. C. Cole
    Kalb, Robert E.
    Jakus, Jeannette
    Mangold, Aaron R.
    Flowers, R. Hal
    Bhutani, Tina
    Durkin, John R.
    Bagel, Jerry
    Fretzin, Scott
    Sheehan, Michael P.
    Krell, James
    Reeder, Margo
    Kaffenberger, Jessica
    Kartono, Francisca
    Takeshita, Junko
    Bridges, Alisha M.
    Fielding, Eric
    Nehal, Umbereen S.
    Schaecher, Kenneth L.
    Howard, Leah M.
    Eakin, Guy S.
    Baez, Suzette
    Bishop, Brooke E.
    Fitzsimmons, Robert C.
    Papadopoulos, Maryte
    Song, William B.
    Linn, Kristin A.
    Hubbard, Rebecca A.
    Shin, Daniel B.
    Callis Duffin, Kristina
    JAMA DERMATOLOGY, 2024, 160 (12) : 1320 - 1328